Trial Details

TERMINATED
Basic Information
Clinical ID c726
Identifier NCT01164904
Trial Title Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Amg 181
Participant Information
Sponsor Amgen
City Glendale
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-07-10
Primary Completion Date 2025-01-13
Completion Date 2025-03-13